Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Macarena Rey-Cardenas"'
Autor:
Jean-Yves Scoazec, Francois-Xavier Danlos, Laurence Albiges, Bernard Escudier, Ronan Flippot, Lydie Cassard, Nathalie Chaput, Natacha Naoun, Marie Naigeon, Jean-Mehdi Jouniaux, Lisa Boselli, Lucia Carril-Ajuria, Marcus Teixeira, Macarena Rey-Cardenas, Larissa Rainho
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 4 (2024)
Immunotherapy profoundly changed the landscape of cancer therapy by providing long-lasting responses in subsets of patients and is now the standard of care in several solid tumor types. However, immunotherapy activity beyond conventional immune check
Externí odkaz:
https://doaj.org/article/4d45ec442ac34e56a8ca723b8b181cf8
Autor:
Ramon Yarza, Mateo Bover, Mercedes Herrera-Juarez, Macarena Rey-Cardenas, Luis Paz-Ares, Jose A Lopez-Martin, John Haanen
Publikováno v:
The Oncologist.
Background T-cell receptor (TCR-T) therapies are based on the expression of an introduced TCR targeting a tumor associated antigen (TAA) which has been studied in several trials in cutaneous melanoma. We conducted a systematic review and meta-analysi
Autor:
Santiago Terán, Manuel Alva, Pablo Tolosa, Macarena Rey-Cárdenas, Ainhoa Madariaga, Laura Lema, Yolanda Ruano, Luis Manso, Eva Ciruelos, Rodrigo Sánchez-Bayona
Publikováno v:
Breast, Vol 71, Iss , Pp 42-46 (2023)
Background: HER2-low has emerged as a new predictive biomarker in metastatic breast cancer. However, its prognostic value in early-stage carcinomas needs to be revisited. We aimed to evaluate the association of HER2-low carcinomas with PAM50 risk gro
Externí odkaz:
https://doaj.org/article/45206221d7664a38bf63504773e67ed3
Autor:
Macarena Rey-Cárdenas, Lucia Parrilla-Rubio, Luis Manso, Rodrigo Sanchez-Bayona, Carmen Alvarez-Conejo, Ainhoa Madariaga
Publikováno v:
Gynecologic Oncology Reports, Vol 49, Iss , Pp 101278- (2023)
Externí odkaz:
https://doaj.org/article/128d5d57d5064c60a04d1c2eb5e9a4d4